Cytokinetics Inc (STU:KK3A) Stock News, Headlines & Updates
Cytokinetics Inc Stock News from GuruFocus
- 1
Jun 18, 2024
Insider Selling: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
GuruFocus Research • 11:49pm
Jun 17, 2024
Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
Marketwired • 7:00am
Jun 12, 2024
Insider Sale at Cytokinetics Inc (CYTK) by EVP of Research & Development
GuruFocus Research • 12:37am
Jun 10, 2024
Insider Sale: Director Muna Bhanji Sells Shares of Cytokinetics Inc (CYTK)
GuruFocus Research • 5:00pm
Jun 05, 2024
Insider Sale: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
GuruFocus Research • 1:00am
Jun 04, 2024
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 3:00pm
Insider Sale: VP, Chief Accounting Officer Robert Wong Sells Shares of Cytokinetics Inc (CYTK)
GuruFocus Research • 12:38am
May 29, 2024
Cytokinetics to Participate in June Investor Conferences
Marketwired • 3:00pm
May 28, 2024
Cytokinetics Announces Closing of Public Offering of Common Stock
Marketwired • 3:00pm
May 23, 2024
Cytokinetics Announces Pricing of Public Offering of Common Stock
GlobeNewswire • 11:00pm
Cytokinetics Announces Pricing of Public Offering of Common Stock
Marketwired • 11:00pm
May 22, 2024
Cytokinetics Announces Proposed Public Offering of Common Stock
Marketwired • 4:00pm
Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
Marketwired • 3:00pm
May 17, 2024
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
Marketwired • 7:00am
May 15, 2024
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024
Marketwired • 7:00am
May 13, 2024
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress
Marketwired • 9:00am
May 10, 2024
Cytokinetics Inc (CYTK) Reports Q1 2024 Earnings: Widening Losses Amid Expansive Clinical Trials
GuruFocus Research • 10:37am
May 09, 2024
Cytokinetics Inc (CYTK) Q1 2024 Earnings Call Transcript Highlights: Navigating Through Development and Regulatory Milestones
GuruFocus Research • 5:01am
Q1 2024 Cytokinetics Inc Earnings Call Transcript
GuruFocus Research • 4:30am
May 08, 2024
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Marketwired • 7:00am
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
Marketwired • 7:00am
Insider Sale at Cytokinetics Inc (CYTK): EVP Research & Development Fady Malik Sells Shares
GuruFocus Research • 12:23am
May 07, 2024
Cytokinetics to Hold Annual Meeting of Stockholders
Marketwired • 3:00pm
May 02, 2024
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 3:00pm
Apr 29, 2024
Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Marketwired • 3:00pm
Apr 24, 2024
Cytokinetics to Announce First Quarter Results on May 8, 2024
Marketwired • 3:00pm
Apr 10, 2024
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Marketwired • 7:00am
Apr 09, 2024
EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
GuruFocus Research • 5:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news